YPSN Overzicht aandelen
Ypsomed Holding AG ontwikkelt, produceert en verkoopt samen met haar dochterondernemingen injectie- en infusiesystemen voor farmaceutische en biotechnologische bedrijven. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 0/6 |
Ypsomed Holding AG Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | CHF 353.50 |
| 52 Week Hoogtepunt | CHF 439.00 |
| 52 Week Laag | CHF 287.50 |
| Bèta | 0.97 |
| 11 maand verandering | -12.82% |
| 3 maanden verandering | -8.54% |
| 1 Jaar Verandering | 17.05% |
| 33 jaar verandering | 103.86% |
| 5 jaar verandering | 160.69% |
| Verandering sinds IPO | 377.70% |
Recent nieuws en updates
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings
Nov 20
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results
Nov 17Recent updates
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings
Nov 20Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results
Nov 17Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects
Aug 13There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jul 31If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity
Jul 03Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise
Jun 19Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?
Jun 10Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results
May 25Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects
May 08Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital
Apr 07Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?
Mar 09Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today
Feb 07We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt
Jan 23Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear
Jan 08Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Dec 23Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?
Dec 05Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?
Sep 28Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
Sep 10Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital
Aug 23Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?
Aug 08Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?
Jun 13Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
May 28What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?
May 06Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital
Apr 21At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?
Feb 01These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well
Jan 17Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?
Dec 27Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings
Nov 24What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?
Oct 19Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching
Jul 14Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jun 20Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?
Feb 28Rendement voor aandeelhouders
| YPSN | CH Medical Equipment | CH Markt | |
|---|---|---|---|
| 7D | -1.3% | -0.6% | 0.5% |
| 1Y | 17.1% | 9.5% | 6.3% |
Rendement versus industrie: YPSN overtrof de Swiss Medical Equipment industrie, die het afgelopen jaar een rendement 9.5 % opleverde.
Rendement versus markt: YPSN overtrof de Swiss markt, die het afgelopen jaar een rendement opleverde van 6.3 %.
Prijsvolatiliteit
| YPSN volatility | |
|---|---|
| YPSN Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 4.0% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.8% |
| 10% least volatile stocks in CH Market | 1.6% |
Stabiele aandelenkoers: De aandelenkoers van YPSN is de afgelopen 3 maanden volatiel geweest.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van YPSN is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen Swiss.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1984 | 2,600 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG ontwikkelt, produceert en verkoopt samen met haar dochterondernemingen injectie- en infusiesystemen voor farmaceutische en biotechnologische bedrijven. Het bedrijf opereert via twee segmenten, Ypsomed Delivery Systems en Ypsomed Diabetes Care. Het segment Ypsomed Delivery Systems levert verschillende injectiesystemen, zoals peninjectoren, auto-injectoren en draagbare injectoren, evenals andere slimme apparaten.
Ypsomed Holding AG Samenvatting
| YPSN fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | CHF 4.83b |
| Inkomsten(TTM) | CHF 74.39m |
| Inkomsten(TTM) | CHF 617.07m |
64.9x
Koers/Winstverhouding7.8x
P/S-verhoudingIs YPSN overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| YPSN resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CHF 617.07m |
| Kosten van inkomsten | CHF 398.41m |
| Brutowinst | CHF 218.66m |
| Overige uitgaven | CHF 144.28m |
| Inkomsten | CHF 74.39m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 5.45 |
| Brutomarge | 35.44% |
| Nettowinstmarge | 12.05% |
| Schuld/Eigen Vermogen Verhouding | 52.3% |
Hoe presteerde YPSN op de lange termijn?
Bekijk historische prestaties en vergelijking